Atrandi Biosciences: Funding, Investors & Team (Oct 2026)
Atrandi Biosciences is a privately owned biotechnology company that specializes in advanced single-cell technology, with a focus on eukaryotic DNA sequencing at the single-cell level. This unique method enables the examination of genetic changes and variations in individual cells.
Atrandi Biosciences has raised $29.8M across 2 funding rounds on record, the most recent a Series A of $25.0M announced in Feb 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Atrandi Biosciences Company Profile and Key Stats
Latest funding round on record: Feb 2025.
Atrandi Biosciences Funding Rounds
Atrandi Biosciences raised $4.8M in a Series A announced in Mar 2023.
1.9 years later, a Series A of $25.0M was announced in Feb 2025.
Atrandi Biosciences Founders and Leadership Team
Contact details for the Atrandi Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Atrandi Biosciences Funding Compared to Other Biotechnology Startups
Atrandi Biosciences' latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Atrandi Biosciences in Biotechnology and Vilnius
Companies Similar to Atrandi Biosciences
Biomatter is a company specializing in synthetic biology that creates new proteins for medical and…
Biohifas employs the power of mycelium and valorizes industrial side streams into the food. We are developing…
BioLinker is a creation of manufactured science, protein blend packs, and protein.
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs…
Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.
M-Based develops new alternative material technologies using mushrooms. 🍄 We consider environmental…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Atrandi Biosciences Funding FAQs
What does Atrandi Biosciences do?
Atrandi Biosciences is a privately owned biotechnology company that specializes in advanced single-cell technology, with a focus on eukaryotic DNA sequencing at the single-cell level. This unique method enables the examination of genetic changes and variations in individual cells.
How much funding has Atrandi Biosciences raised?
Atrandi Biosciences has raised $29.8M across 2 rounds on record. The most recent is a Series A of $25.0M announced in Feb 2025.
When did Atrandi Biosciences last raise funding?
Atrandi Biosciences' most recent funding round on record is a Series A of $25.0M, announced in Feb 2025.
Who founded Atrandi Biosciences?
FundedIQ lists Juozas Nainys (Founder) at Atrandi Biosciences.
Where is Atrandi Biosciences headquartered?
Atrandi Biosciences is based in Vilnius, Vilniaus Apskritis, Lithuania.
How many employees does Atrandi Biosciences have?
Atrandi Biosciences is in the 101-250 employee band.
How does Atrandi Biosciences' funding compare to other Biotechnology startups?
Atrandi Biosciences' latest round of $25.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Atrandi Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Atrandi Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.